Multimodal and Multiparametric Molecular Imaging in Fibroproliferative Diseases

Learn more below.

Previous
Previous

Imaging-Based Tools to Enhance Signals of Efficacy in Early Stages of Oncology Clinical Development

Next
Next

ICH GCP E6 (R3) and Potential Requirements for Imaging in Clinical Trials